We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

New Drug Target for Acute Myeloid Leukaemia

News   Nov 28, 2017 | Original story from Wellcome Trust Sanger Institute

 
New Drug Target for Acute Myeloid Leukaemia

Acute myeloid leukamia (AML) cells. Genomic research has found that AML cannot survive without the METTL3 gene, making it a strong therapeutic target. Image credit: The Armed Forces Institute of Pathology (AFIP)

 
 
Advertisement
 

RELATED ARTICLES

Biochemical Pathway Discovered That Protects Cells From Ferroptosis

News

In an article published in Cell Metabolism, Moffitt Cancer Center researchers report on a newly discovered biochemical pathway that protects cells from a type of cell death called ferroptosis.

READ MORE

Drug May Reduce Tumor Volume in Neurofibromatosis

News

Based on preclinical studies of an investigational drug to treat peripheral nerve tumors, researchers have shown that the drug, cabozantinib, reduces tumor volume and pain in patients with the genetic disorder neurofibromatosis type 1 (NF1).

READ MORE

Reverse Engineering Highly Detailed Models of Chromosomes

News

Researchers at the University of Illinois Chicago report on a computational technique that uses heat map data to reverse engineer highly detailed models of chromosomes.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE